Elevated Monocyte to High-density Lipoprotein Ratios as an Inflammation Markers for Schizophrenia Patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: Monocyte to high density lipoprotein ratio (MHR) is a new instrument for giving notice inflammation, which plays a main role in schizophrenia. Thus, in this study, our goal was to investigate the possible association between MHR and schizophrenia. Methods: The participants of this study consisted of 75 schizophrenia patients and 74 healthy individuals (control group). The Positive and Negative Syndrome Scale was used to collect data from the patient group. Complete blood count parameters and lipid profile were analyzed in all study participants. Results: The patients with schizophrenia had higher MHR values (15.04 ± 3.31 in schizophrenia patients and 12.62 ± 2.99 in controls; p = 0.001). Monocyte counts and MHR of the schizophrenia patients were significantly higher than the control group. There was a significant and positive correlation between age, body mass index, severity of disease and MHR. Conclusion: To our knowledge, this study was the first to demonstrate inflammatory markers such as MHR levels in schizophrenia patients. Both monocyte counts and MHR values in schizophrenia patients were higher than the control group. MHR might be an available and useful inflammatory marker to evaluate inflammation in schizophrenia patients.
Abstract
Objective: Monocyte to high density lipoprotein ratio (MHR) is a new instrument for giving notice inflammation, which plays a main role in schizophrenia. Thus, in this study, our goal was to investigate the possible association between MHR and schizophrenia. Methods: The participants of this study consisted of 75 schizophrenia patients and 74 healthy individuals (control group). The Positive and Negative Syndrome Scale was used to collect data from the patient group. Complete blood count parameters and lipid profile were analyzed in all study participants. Results: The patients with schizophrenia had higher MHR values (15.04 ± 3.31 in schizophrenia patients and 12.62 ± 2.99 in controls; p = 0.001). Monocyte counts and MHR of the schizophrenia patients were significantly higher than the control group. There was a significant and positive correlation between age, body mass index, severity of disease and MHR. Conclusion: To our knowledge, this study was the first to demonstrate inflammatory markers such as MHR levels in schizophrenia patients. Both monocyte counts and MHR values in schizophrenia patients were higher than the control group. MHR might be an available and useful inflammatory marker to evaluate inflammation in schizophrenia patients.
참고문헌 (29)
- Filiz Karadag, "Relationship between Serum Bilirubin Levels and Metabolic Syndrome in Patients with Schizophrenia Spectrum Disorders", Clinical Psychopharmacology and Neuroscience, 15(2), pp.153~162 (2017), 대한정신약물학회[DOI]
- Miller BJ, "Meta-analysis of cytokine alterations in schizophrenia : clinical status and antipsychotic effects", Biol Psychiatry, 70, pp.663~671 (2011)
- Correll CU, "Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness : a large-scale meta-analysis of 3, 211, 768 patients and 113, 383, 368 controls", World Psychiatry, 16, pp.163~180 (2017)
- Qiu C, "A major role for cardiovascular burden in age-related cognitive decline", Nat Rev Cardiol, 12, pp.267~277 (2015)
- Kaffashian S, "Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores", Neurology, 80, pp.1300~1306 (2013)
- Zhang C, "Metabolic adverse effects of olanzapine on cognitive dysfunction : a possible relationship between BDNF and TNFalpha", Psychoneuroendocrinology, 81, pp.138~143 (2017)
- MacKenzie NE, "Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia", Front Psychiatry, 9, pp.622~ (2018)
- Barter PJ, "Antiinflammatory properties of HDL", Circ Res, 95, pp.764~772 (2004)
- Negi G, "Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy : old perspective with a new angle", Biochem Biophys Res Commun, 408, pp.1~5 (2011)
- Abacioglu OO, "Monocyte to high-density lipoprotein ratio: a prognostic factor for mitral valve prolapse", Bratisl Lek Listy, 121, pp.151~153 (2020)
- Canpolat U, "Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation", Clin Appl Thromb Hemost, 22, pp.476~482 (2016)
- Kaplan IG, "Monocyte", HDL ratio predicts hypertensive complications, 2020, pp.121, 133~136
- Kay SR, "The positive and negative syndrome scale(PANSS)for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
- Enhos A, "Assessment of the relationship between monocyte to high-density lipoprotein ratio and myocardial bridge", Arq Bras Cardiol, 112, pp.12~17 (2019)
- Vahit D, "Assessment of monocyte to high density lipoprotein cholesterol ratio and lymphocyte-to-monocyte ratio in patients with metabolic syndrome", Biomark Med, 11, pp.535~540 (2017)
- Yılmaz M, "A new inflammatory marker : elevated monocyte to HDL cholesterol ratio associated with smoking", J Clin Med, 7, pp.76~ (2018)
- Dogan A, "Increased monocyte-to-HDL cholesterol ratio is related to cardiac syndrome X", Acta Cardiol, 72, pp.516~521 (2017)
- Kundi H, "Relation between monocyte to high-density lipoprotein cholesterol ratio with presence and severity of isolated coronary artery ectasia", Am J Cardiol, 116, pp.1685~1689 (2015)
- Acikgoz N, "Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in Behçet disease", Angiology, 69, pp.65~70 (2018)
- Johnsen SH, "Monocyte count is a predictor of novel plaque formation : a 7-year follow-up study of 2610 persons without carotid plaque at baseline the Tromsø Study", Stroke, 36, pp.715~719 (2005)
- Kanbay M, "Monocyte count", HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease, 2014, pp.46, 1619~1625
- Barter PJ, "Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells", Curr Opin Lipidol, 13, pp.285~288 (2002)
- Açıkgöz SK, "Monocyte to high-density lipoprotein cholesterol ratio is predictive of in-hospital and five-year mortality in ST-segment elevation myocardial infarction", Cardiol J, 23, pp.505~512 (2016)
- Murphy AJ, "High-density lipoprotein reduces the human monocyte inflammatory response", Arterioscler Thromb Vasc Biol, 28, pp.2071~2077 (2008)
- Cetin EH, "Monocyte", HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction, 2015, pp.9, 967~977
- Bergink V, "Autoimmunity, inflammation, and psychosis : a search for peripheral markers", Biol Psychiatry, 75, pp.324~331 (2014)
- Drexhage RC, "Inflammatory gene expression in monocytes of patients with schizophrenia:overlap and difference with bipolar disorder. A study in naturalistically treated patients", Int J Neuropsychopharmacol, 13, pp.1369~1381 (2010)
- Huang MC, "Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan", Acta Psychiatr Scand, 120, pp.274~280 (2009)
- Huang TL, "Serum lipid profiles and schizophrenia:effects of conventional or atypical antipsychotic drugs in Taiwan", Schizophr Res, 80, pp.55~59 (2005)
